Cargando…
_version_ 1784826219251892224
author Gallamini, Andrea
Picardi, Marco
Filonenko, Kateryna
Gotti, Manuel
Céspedes, Javier Núñez
Rossi, Andrea
Domingo-Domènech, Eva
Giza, Agnieszka
Sorasio, Roberto
Trentin, Livio
Oteiro, Mariana Bastos
Paszkiewicz-Kozik, Ewa
Sanz, Ramon García
Patti, Caterina
Chauvie, Stephane
Bergesio, Fabrizio
Guerra, Luca
Rambaldi, Alessandro
Balari, Ana Sureda
Zaucha, Jan Maciej
author_facet Gallamini, Andrea
Picardi, Marco
Filonenko, Kateryna
Gotti, Manuel
Céspedes, Javier Núñez
Rossi, Andrea
Domingo-Domènech, Eva
Giza, Agnieszka
Sorasio, Roberto
Trentin, Livio
Oteiro, Mariana Bastos
Paszkiewicz-Kozik, Ewa
Sanz, Ramon García
Patti, Caterina
Chauvie, Stephane
Bergesio, Fabrizio
Guerra, Luca
Rambaldi, Alessandro
Balari, Ana Sureda
Zaucha, Jan Maciej
author_sort Gallamini, Andrea
collection PubMed
description
format Online
Article
Text
id pubmed-9642047
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96420472022-11-14 T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial. Gallamini, Andrea Picardi, Marco Filonenko, Kateryna Gotti, Manuel Céspedes, Javier Núñez Rossi, Andrea Domingo-Domènech, Eva Giza, Agnieszka Sorasio, Roberto Trentin, Livio Oteiro, Mariana Bastos Paszkiewicz-Kozik, Ewa Sanz, Ramon García Patti, Caterina Chauvie, Stephane Bergesio, Fabrizio Guerra, Luca Rambaldi, Alessandro Balari, Ana Sureda Zaucha, Jan Maciej Hemasphere Early Stages Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642047/ http://dx.doi.org/10.1097/01.HS9.0000890652.56016.97 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Early Stages
Gallamini, Andrea
Picardi, Marco
Filonenko, Kateryna
Gotti, Manuel
Céspedes, Javier Núñez
Rossi, Andrea
Domingo-Domènech, Eva
Giza, Agnieszka
Sorasio, Roberto
Trentin, Livio
Oteiro, Mariana Bastos
Paszkiewicz-Kozik, Ewa
Sanz, Ramon García
Patti, Caterina
Chauvie, Stephane
Bergesio, Fabrizio
Guerra, Luca
Rambaldi, Alessandro
Balari, Ana Sureda
Zaucha, Jan Maciej
T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title_full T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title_fullStr T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title_full_unstemmed T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title_short T021: Radiation-Free Therapy as the INitial treatment of Good-prognosis early non-bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET-2 - RAFTING Trial.
title_sort t021: radiation-free therapy as the initial treatment of good-prognosis early non-bulky hodgkin lymphoma, defined by a low metabolic tumor volume and a negative pet-2 - rafting trial.
topic Early Stages
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642047/
http://dx.doi.org/10.1097/01.HS9.0000890652.56016.97
work_keys_str_mv AT gallaminiandrea t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT picardimarco t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT filonenkokateryna t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT gottimanuel t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT cespedesjaviernunez t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT rossiandrea t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT domingodomenecheva t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT gizaagnieszka t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT sorasioroberto t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT trentinlivio t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT oteiromarianabastos t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT paszkiewiczkozikewa t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT sanzramongarcia t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT patticaterina t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT chauviestephane t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT bergesiofabrizio t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT guerraluca t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT rambaldialessandro t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT balarianasureda t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial
AT zauchajanmaciej t021radiationfreetherapyastheinitialtreatmentofgoodprognosisearlynonbulkyhodgkinlymphomadefinedbyalowmetabolictumorvolumeandanegativepet2raftingtrial